The year in cardiology 2016: prevention
█ Current Opinion
Massimo F. Piepoli1, Stefano Taddei2, and Ulrich Laufs3
1Heart Failure Unit, Cardiology, G da Saliceto Hospital, AUSL Piacenza, 29121, Piacenza, Italy
2Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy
3Klinik für Innere Medizin III, IMED 41.1; UdS; Universität des Saarlandes, 66421, Homburg, Germany
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
Cardiovascular disease (CVD) accounts for most of the deaths from non-communicable diseases, or 17.5 million people annually in Europe (1). The new 2016 European Society of Cardiology (ESC) European Guidelines on CVD prevention in clinical practice, (developed by the Sixth Joint Task Force of the ESC and nine other societies) emphasize, for the first time in an European Guidelines, not only an individual-based approach but also a population-based intervention, focusing on smoking cessation, a healthy diet, physical activity, alcohol abuse prevention, and a healthy environment promotion (2). Also new aspect of the 2016 Guidelines is the presentation of preventive measures targeted at specific groups (e.g. younger and older persons; women; ethnic minorities; patients with inflammatory diseases or under cancer therapy). In the present article, we summarize some of the interesting novel insights in the field of CVD prevention published in the year 2016.